Financials
- Market Capitalization 652.72 M
- Employee 191
- Founded 2006
- CEO N/A
- Website www.cormedix.com
- Headquarter Delaware, United States
- FIGI BBG000Q4BQK0
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
5.7
Rapporto prezzo/fatturato
0
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2728 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.93 USD | -3.50% | -8.10% | 0.00% | +49.61% | 666.15 M USD | ||
| 2740 | RGNX REGENXBIO Inc. - Common Stock | 12.75 USD | -8.60% | -14.03% | +87.78% | -5.06% | 659.14 M USD | ||
| 2748 | TECX Tectonic Therapeutic, Inc. - Common Stock | 34.34 USD | -0.09% | -2.75% | +12.00% | +100.23% | 647.97 M USD | ||
| 2761 | PRME Prime Medicine, Inc. - Common Stock | 3.52 USD | -6.88% | -13.30% | +20.55% | -27.42% | 635.77 M USD |